Exploration of the methods of establishing the minimum clinical important difference based on anchors and their applications in the quality of life measurement scale QLICP-BR (V2.0) for breast cancer

OBJECTIVE: The measurement of the quality of life (QOL) in patients with breast cancer can evaluate the therapeutic effects of medical treatments and help to provide reference for clinical decisions. The minimum clinically important difference (MCID) can be better used in clinical interpretation tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xuan, Liu, Yuxi, Tan, Jianfeng, Hu, Liren, Chen, Huanwei, Wan, Chonghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083364/
https://www.ncbi.nlm.nih.gov/pubmed/37051543
http://dx.doi.org/10.3389/fonc.2023.1123258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083364/
https://www.ncbi.nlm.nih.gov/pubmed/37051543
http://dx.doi.org/10.3389/fonc.2023.1123258

Ejemplares similares